An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Breast Cancer
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Breast Cancer
Interventions: DRUG: Bevacizumab
Sponsor: Hoffmann-La Roche